Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The feds say restrict opioid use. Now what?

Cindy Perlin, LCSW
Meds
March 15, 2017
Share
Tweet
Share

The federal government has declared, through its major health policy agencies, that the number of pain patients on opioids and the dosages they are on should be severely restricted.  The Center for Disease Control (CDC), Veteran’s Administration (VA) and Centers for Medicare and Medicaid Services (CMS) have all issued new guidelines within the past year to that effect.  Private insurers are following suit, in many cases refusing to pay for high dose opioids.

More recently, the American College of Physicians issued new guidelines for the treatment of low back pain that recommend using nonpharmacological therapies before prescribing any medication. They made this recommendation after a review of the research indicated that therapies such as massage, acupuncture, biofeedback and spinal manipulation have greater effectiveness and lower risks than any pharmaceutical. These therapies get to the root of the problem rather than just treating the symptom.

It has become clear that opioids are dangerous for many people who take them.  Widespread prescribing of opioids has led to an epidemic of opioid addiction and overdose deaths that has destroyed individuals, families and many communities.  However, this sudden policy shift is highly problematic.

During the last two decades when pain patients were being offered opioids as their primary treatment for sometimes very severe and complex pain conditions, many patients became dependent on opioids as their sole treatment.  Now many are being withdrawn, often abruptly, with no other treatment being offered, with sometimes devastating results.  Suffering has increased, suicides are being reported, and some are turning to heroin.  Other pharmaceuticals have limited effectiveness or poor safety profiles.

At the same time as opioids were being pushed as a panacea for chronic pain, health insurers did their best to dismantle the health system infrastructure as it related to pain treatment.  Physical therapists, occupational therapists, chiropractors, and psychotherapists have not had increases in fees from insurance companies for almost 40 years. In addition, the number of allowed visits for these therapies has become more and more restrictive.  (The exception for visit limits is psychotherapy, because of a federal mental health parity law that took effect in 2011.) As a result, the number of practitioners in these fields has shrunk significantly, and shortages are common, particularly for mental health practitioners and physical therapists.  In addition, health insurers refused to pay for interdisciplinary pain treatment programs, the most successful model of care.  The number of these programs has shrunk, from over a thousand in the early 90s to less than 50 today.  Even where these services continue to be available and are covered, most patients cannot afford them because of high copays.

Other treatments that are proven effective for chronic pain such as massage, acupuncture, biofeedback, exercise programs and low-level laser therapy, are not covered at all.  Lack of insurance coverage has also limited the number of practitioners coming into these fields.

We need to require insurance companies to pay for these therapies at a reimbursement level that is adequate to attract new providers, with copays that are affordable for pain patients.  Even with these changes, it will take years to bring enough providers into these fields to adequately meet the needs of the 100 million Americans in chronic pain.

Another natural remedy that could be quickly available that is both safe and effective is medical marijuana.  Marijuana not only helps with pain and many other illnesses with no serious adverse effects, it helps ease withdrawal symptoms and prevents development of tolerance in opioid users. Inexplicably, the U.S. Drug Enforcement Agency (DEA) refuses to reclassify marijuana from a Schedule 1 drug (high potential for abuse and no known medical benefits) to an alternate classification that would make it legal under federal law. Though 29 states and the District of Columbia have approved medical marijuana, these programs operate in a legally gray area, and insurance reimbursement is not available.

Chronic pain causes great suffering and costs our economy over $600 billion a year.  It’s time to vigorously address this problem.

Cindy Perlin is a social worker and author of The Truth About Chronic Pain Treatments: The Best and Worst Strategies for Becoming Pain Free.

Image credit: Shutterstock.com

Prev

My mother isn't a drug-seeking patient. She's in pain.

March 15, 2017 Kevin 0
…
Next

This the one thing that makes me feel like everything is OK

March 15, 2017 Kevin 0
…

Tagged as: Pain Management

Post navigation

< Previous Post
My mother isn't a drug-seeking patient. She's in pain.
Next Post >
This the one thing that makes me feel like everything is OK

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by Cindy Perlin, LCSW

  • Why physicians need to become more educated about alternative pain treatments

    Cindy Perlin, LCSW
  • From suffering to healing: the role of trauma in chronic pain

    Cindy Perlin, LCSW
  • It’s time for a reckoning in pain medicine

    Cindy Perlin, LCSW

Related Posts

  • The triangle of blame for the opioid epidemic

    Sangrag Ganguli and Uche Ezeh
  • Marijuana will not fix the opioid epidemic

    Kenneth Finn, MD
  • The other opioid epidemic that we ignore

    Hans Duvefelt, MD
  • How do we manage pain in the era of the opioid crisis?

    Rita Agarwal, MD
  • Americans and Canadians use more post-surgery opioid pain pills

    Julie Appleby
  • A patient’s opposition to the anti-opioid movement

    Angelika Byczkowski

More in Meds

  • Why retail pharmacies are the future of diverse clinical trials

    Shelli Pavone
  • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

    Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO
  • A world without antidepressants: What could possibly go wrong?

    Tomi Mitchell, MD
  • The truth about GLP-1 medications for weight loss: What every patient should know

    Nisha Kuruvadi, DO
  • The hidden bias in how we treat chronic pain

    Richard A. Lawhern, PhD
  • Biologics are not small molecules: the case for pre-allergy testing in an era of immune-based therapies

    Robert Trent
  • Most Popular

  • Past Week

    • Why removing fluoride from water is a public health disaster

      Steven J. Katz, DDS | Conditions
    • When did we start treating our lives like trauma?

      Maureen Gibbons, MD | Physician
    • First impressions happen online—not in your exam room

      Sara Meyer | Social media
    • How Gen Z is transforming mental health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Dedicated hypermobility clinics can transform patient care

      Katharina Schwan, MPH | Conditions
    • Why ADHD in adults is often missed—and why it matters [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • Why recovery after illness demands dignity, not suspicion

      Trisza Leann Ray, DO | Physician
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
    • Why medical students are trading empathy for publications

      Vijay Rajput, MD | Education
  • Recent Posts

    • How Gen Z is transforming mental health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Nurses aren’t eating their young — we’re starving the profession

      Adam J. Wickett, BSN, RN | Conditions
    • Why wanting more from your medical career is a sign of strength

      Maureen Gibbons, MD | Physician
    • U.S. health care leadership must prepare for policy-driven change

      Lee Scheinbart, MD | Policy
    • Why the pre-med path is pushing future doctors to the brink

      Jordan Williamson, MEd | Education
    • Why the fear of being forgotten is stronger than the fear of death [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 38 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why removing fluoride from water is a public health disaster

      Steven J. Katz, DDS | Conditions
    • When did we start treating our lives like trauma?

      Maureen Gibbons, MD | Physician
    • First impressions happen online—not in your exam room

      Sara Meyer | Social media
    • How Gen Z is transforming mental health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Dedicated hypermobility clinics can transform patient care

      Katharina Schwan, MPH | Conditions
    • Why ADHD in adults is often missed—and why it matters [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • Why recovery after illness demands dignity, not suspicion

      Trisza Leann Ray, DO | Physician
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
    • Why medical students are trading empathy for publications

      Vijay Rajput, MD | Education
  • Recent Posts

    • How Gen Z is transforming mental health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Nurses aren’t eating their young — we’re starving the profession

      Adam J. Wickett, BSN, RN | Conditions
    • Why wanting more from your medical career is a sign of strength

      Maureen Gibbons, MD | Physician
    • U.S. health care leadership must prepare for policy-driven change

      Lee Scheinbart, MD | Policy
    • Why the pre-med path is pushing future doctors to the brink

      Jordan Williamson, MEd | Education
    • Why the fear of being forgotten is stronger than the fear of death [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

The feds say restrict opioid use. Now what?
38 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...